Used as a potent inhibitor in targeted cancer therapies, particularly in the development of kinase inhibitors for treating various solid tumors and hematological malignancies. It demonstrates strong activity against receptor tyrosine kinases involved in cell proliferation and angiogenesis, making it valuable in oncology research. Its structure allows for high selectivity and binding affinity, improving efficacy in signaling pathway modulation. Commonly employed in preclinical studies to evaluate antitumor activity and pharmacokinetic profiles.